Table 2 |
||||
|
Correlation of anti-PM1-α and other known autoantibodies |
||||
|
Number positive/all sera (% positive) |
Number positive/PM1-α-positives (% positive) |
Number positive/PM1-α-negatives (% positive) |
P |
|
|
|
||||
|
Scl-70 |
0/28 (0) |
0/15 (0) |
0/13 (0) |
* |
|
Sm |
0/28 (0) |
0/15 (0) |
0/13 (0) |
* |
|
Rib-P |
1/28 (3.6) |
1/15 (6.7) |
0/13 (0) |
* |
|
RNP |
4/28 (14.4) |
1/15 (6.7) |
3/13 (23.1) |
* |
|
Chromatin |
1/28 (3.6) |
1/15 (6.7) |
0/13 (0%) |
* |
|
Ro-52 |
18/70 (25.7) |
6/19 (31.6) |
12/51 (23.5) |
0.7056 |
|
Ro-60 |
6/70 (8.6) |
2/19 (10.6) |
4/51 (7.8) |
0.9018 |
|
La |
3/70 (4.3) |
1/19 (5.3) |
2/51 (3.9) |
0.6766 |
|
Mi-2 |
10/70 (14.3) |
3/19 (15.8) |
7/51 (13.7) |
0.8693 |
|
Jo-1 |
16/70 (22.9) |
1/19 (5.2) |
15/51 (29.4) |
0.0688 |
|
|
||||
|
* Not calculated due to the limited number of samples. |
||||
|
Mahler et al. Arthritis Research & Therapy 2005 7:R704 doi:10.1186/ar1729 |
||||
